INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 9, p. 1502–1518, 2024. DOI: 10.53555/68zhqm37. Disponível em: https://jptcp.com/index.php/jptcp/article/view/7959. Acesso em: 28 sep. 2024.